Latest Data on Evobrutinib, New MS Therapy Targeting B Cells Latest Data on Evobrutinib, New MS Therapy Targeting B Cells

Further data from the phase 2 trial of show a significant reduction in enhancing MRI lesions with one of the doses tested but increases in liver enzymes may be an issue.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news